Inovio Pharmaceuticals Inc banner

Inovio Pharmaceuticals Inc
F:GBM

Watchlist Manager
Inovio Pharmaceuticals Inc Logo
Inovio Pharmaceuticals Inc
F:GBM
Watchlist
Price: 0.9565 EUR -6.32%
Market Cap: €65.7m

Wall St Price Targets

GBM Price Targets Summary
Inovio Pharmaceuticals Inc

Wall Street analysts forecast GBM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GBM is 5.6856 EUR with a low forecast of 1.4991 EUR and a high forecast of 11.2554 EUR.

Lowest Forecast
Price Target
1.4991 EUR
57% Upside
Average Forecast
Price Target
5.6856 EUR
494% Upside
Highest Forecast
Price Target
11.2554 EUR
1 077% Upside
Inovio Pharmaceuticals Inc Competitors:
Price Targets
ANY
ANY Biztonsagi Nyomda Nyrt
-14% Downside
KRNY
Kearny Financial Corp
12% Upside
NSIT
Insight Enterprises Inc
-12% Downside

Revenue
Forecast

-30% / Year
Past Growth
181% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-30% / Year
Past Growth
181% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been -30%. The projected CAGR for the next 8 years is 181%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GBM's stock price target?
Price Target
5.6856 EUR

According to Wall Street analysts, the average 1-year price target for GBM is 5.6856 EUR with a low forecast of 1.4991 EUR and a high forecast of 11.2554 EUR.

What is the Revenue forecast for Inovio Pharmaceuticals Inc?
Projected CAGR
181%

Over the last 14 years, the compound annual growth rate for Revenue has been -30%. The projected CAGR for the next 8 years is 181%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett